financetom
Business
financetom
/
Business
/
BlackRock taps into AI frenzy with two new ETFs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BlackRock taps into AI frenzy with two new ETFs
Oct 22, 2024 12:22 PM

(Reuters) - Asset management giant BlackRock ( BLK ) on Tuesday launched two new exchange-traded funds (ETFs) aimed at giving investors exposure to the booming market for artificial intelligence.

Generative AI, designed to create human-like interactions by processing vast amounts of data, has taken the world by storm and is expected to be integrated into virtually all industries in the coming years from technology to financial services.

"As an investing theme, BlackRock ( BLK ) views AI as a mega force with broad investing implications both now and in the long term," the world's largest asset manager said.

Asset managers have been rolling out thematic ETFs to capitalize on the popularity of certain themes, sectors or trends, unlike traditional products that track broad market indexes.

Demand for these products, however, has been mixed in recent months as investors have been opting for funds linked to stock market benchmarks, which are hovering near record highs.

BlackRock's ( BLK ) iShares A.I. Innovation and Tech Active ETF will invest in global AI and technology stocks across market capitalizations.

Its iShares Technology Opportunities Active ETF shares a similar investment objective, aiming for long-term capital appreciation by investing in global technology companies across sectors like semiconductors, software and hardware, among others.

"These active ETFs can help investors seize outsized and overlooked investment opportunities across the full stack of AI and advanced technologies," said Tony Kim, BlackRock's ( BLK ) head of the fundamental equities technology group.

Earlier this month, the asset manager beat Wall Street estimates for third-quarter profit and its assets under management (AUM) hit a record high as a U.S. stock market rally boosted inflows.

As of Sept 30, its iShares business - with over 1400 ETFs - had $4.2 trillion in AUM.

(Reporting by Manya Saini in Bengaluru; Editing by Anil D'Silva)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Aurion Resources Considering Options Regarding Notice From B2Gold
Aurion Resources Considering Options Regarding Notice From B2Gold
May 6, 2024
08:56 AM EDT, 05/06/2024 (MT Newswires) -- Aurion Resources ( AIRRF ) , which rose 3% on Friday, said Monday that it is considering several options regarding a notice of sale and offer from B2Gold ( BTG ) . In the notice, B2Gold ( BTG ) said it has held talks with several parties to determine its response to the...
Garrett Motion Units to Offer $500 Million Senior Unsecured Notes Due 2032
Garrett Motion Units to Offer $500 Million Senior Unsecured Notes Due 2032
May 6, 2024
08:53 AM EDT, 05/06/2024 (MT Newswires) -- Garrett Motion ( GTX ) said Monday its Garrett Motion ( GTX ) and Garrett LX units are planning to launch a private offering of $500 million total principal amount of senior unsecured notes due 2032. The company intends to utilize the proceeds, plus its cash on hand, to repay term loan indebtedness...
Lyra Therapeutics Phase 3 Trial of LYR-210 Falls Short of Primary Endpoint, Plans to Cut Staff; Shares Drop Pre-Bell
Lyra Therapeutics Phase 3 Trial of LYR-210 Falls Short of Primary Endpoint, Plans to Cut Staff; Shares Drop Pre-Bell
May 6, 2024
08:52 AM EDT, 05/06/2024 (MT Newswires) -- Lyra Therapeutics ( LYRA ) said Monday that the phase 3 of its Enlighten 1 trial, evaluating the company's investigational treatment LYR-210 for chronic rhinosinusitis, failed to meet its primary endpoint at 24 weeks. The drug candidate was generally well tolerated, with no product-related serious adverse events. Data from an ongoing 52-week extension...
What's Going On With Insurance Company Loews' Shares Monday?
What's Going On With Insurance Company Loews' Shares Monday?
May 6, 2024
Loews Corp ( L )  reported first-quarter FY24 net income of $457 million, up 22% Y/Y. EPS of $2.05 was higher than the year-ago figure of $1.61. Revenues were $4.23 billion, higher than $3.78 billion a year ago. CNA Financial Corp ( CNA ) revenue contribution increased to $3.44 billion from $3.15 billion a year ago, and net income rose to $310 million from $268...
Copyright 2023-2026 - www.financetom.com All Rights Reserved